Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001898958 | SCV002168380 | uncertain significance | not provided | 2022-08-07 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 3468 of the HMCN1 protein (p.Ala3468Gly). This variant is present in population databases (rs201041141, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1404200). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004042609 | SCV003682123 | uncertain significance | not specified | 2021-07-20 | criteria provided, single submitter | clinical testing | The c.10403C>G (p.A3468G) alteration is located in exon 68 (coding exon 68) of the HMCN1 gene. This alteration results from a C to G substitution at nucleotide position 10403, causing the alanine (A) at amino acid position 3468 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003452122 | SCV004179869 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |